Selpercatinib mitigates cancer cachexia independent of anti-tumor activity

ABSTRACT: We determine whether the RET protein tyrosine kinase inhibitor selpercatinib alleviates skeletal muscle atrophy in the HT1080 tumor model in mice.

ORGANISM(S): Mus musculus

PROVIDER: GSE271312 | GEO | 2025/05/09

REPOSITORIES: GEO